EEG-Based Brain Health Biomarker
Take the guesswork out of it, know your patient's brain state
Objective 5-minute test for improved delirium management and neurotoxic-related treatments to support timely interventions.
A top public health priority
Acute encephalopathy and delirium are the most common post-op complication in older adults
Each year, approximately 50% of surgical and ICU patients in the US and Europe are at risk of developing acute brain failure and delirium¹.
Annual health system and societal costs are estimated at €320B in the U.S. and EU, rivaling costs associated with heart disease and diabetes².
Yet..
“Up to 88% of delirious patients go undetected in daily care practice³”
Marcantonio, 2017, The New England Journal of Medicine
Stay up to date with the latest news and upcoming events from Prolira DeltaScan®
Our journey so far
Prolira achievements to date
Exclusive technology license from University Medical Center Utrecht
Product Development and 434 patient Multi-Center Study
3 clinical studies completed and enrolling in more
CE certified according to EU MDR since 2020
FDA Clearance
Establishing Clinical & Strategic Partnerships
Interested? Let's get in touch!
Get in touch to learn how you can reshape acute encephalopathy and delirium care delivery
sources: ¹ American Geriatric Society ² Inouye et al. 2014 ³ Marcantonio, et al. N Engl J Med 2017
pageversion: 4.0